Cytek Biosciences, Inc. CTKB United States — Total
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NoncurrentAssets.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s united states — total.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s united states — total?
- Cytek Biosciences, Inc. (CTKB) reported united states — total of $10.52M in Q1 2026.
- How has Cytek Biosciences, Inc.'s united states — total changed year-over-year?
- Cytek Biosciences, Inc.'s united states — total increased by 29.3% year-over-year, from $8.13M to $10.52M.
- What is the long-term trend for Cytek Biosciences, Inc.'s united states — total?
- Over 3 years (2022 to 2025), Cytek Biosciences, Inc.'s united states — total has grown at a 12.9% compound annual growth rate (CAGR), from $22.54M to $32.46M.
- What does united states — total mean?
- This metric captures the aggregate financial contribution of the United States segment to the company's overall operational performance. It serves as a comprehensive indicator of the scale and economic impact of the business activities conducted within this specific geographic market. Monitoring this total allows for the evaluation of regional performance relative to global operations and broader market expansion strategies.